tirzepatide vs semaglutide vs retatrutide Retatrutide: 2026 Chicago Guide Semaglutide vs Tirzepatide vs Retatrutide

In general, dose increases are typically spaced at least 4 weeks apart to help assess tolerability

There is no official link established between semaglutide and direct hormonal disruption of the menstrual cycle

The diagnosis listed by your provider needs to align with that labeling

CMS issued Medicare Part D coverage guidance stating that in instances when an obesity medication receives approval for an additional medically accepted indication during the contract year, Part D sponsors may include such drugs on their current Part D formularies. That means Medicare Part D plans can begin covering tirzepatide for OSA without waiting for the next plan year

The right timing depends on your work schedule, exercise routine, and individual response patterns

For some people, weeks 3 and 4 bring a slight reduction in the appetite-suppressing effect compared to week 1